Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Dendreon plans to lay off 500 following disappointing Provenge uptake
Sep 09 2011
•
By
Nancy Faigen
More from Anticancer
More from Therapeutic Category